Nailfold capillaroscopy reveals early peripheral microcirculation abnormalities in children affected by heterozygous familial hypercholesterolemia

被引:4
|
作者
Martino, Francesco [1 ]
Barilla, Francesco [2 ]
Martino, Eliana [1 ]
Placanica, Giuseppe [3 ]
Paravati, Vincenzo [1 ]
Bassareo, Pier Paolo [4 ,5 ,6 ]
机构
[1] Sapienza Univ Rome, Dept Internal Med Anaesthesiol & Cardiovasc Sci, I-00161 Rome, Italy
[2] Tor Vergata Univ Rome, Dept Syst Med, I-00133 Rome, Italy
[3] Sapienza Univ Rome, Dept Cardiovasc Nephrol Anaesthesiol & Geriatr Sci, I-00133 Rome, Italy
[4] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Sch Med, Dublin, Ireland
[5] Childrens Hlth Ireland Crumlin, Dublin, Ireland
[6] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Sch Med, Eccles St, Dublin D07 R2WY, Ireland
关键词
Nailfold capillaroscopy; Familial hypercholesterolemia; Low-density lipoproteins cholesterol; Children; Sludge phenomenon; FLOW-MEDIATED VASODILATION; FOLLOW-UP; PERICYTES; CHILDHOOD; MICROSCOPY; ARTERY; CAPILLARIES; REACTIVITY; DISEASE;
D O I
10.1016/j.mvr.2023.104545
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: nailfold capillaroscopy (NCF) is a non-invasive imaging technique to seek peripheral microcirculation abnormalities in children and adults. Familial hypercholesterolemia is a genetic disorder caused by mutations capable of increasing blood levels of low-density lipoproteins cholesterol (LDL-C), thus triggering early atherosclerosis. The study aims at evaluating peripheral microcirculation in children with heterozygous familial hypercholesterolemia (HeFH) by means of NFC in comparison with healthy peers and at searching for possible correlations between these abnormalities and patients' lipid panel. Methods: thirty-six HeFH patients were enrolled (13 males and 23 females. Mean age 8 +/- 3 years; age range 3-13 years). They had increased levels of total cholesterol (237.9 +/- 34.2 mg/dl) and LDL-C (154.2 +/- 37.6 mg/dl). Both values were =95th gender and age specific centile. All the subjects in the study underwent NFC. Results: In 69.4 % of HeFH children nailfold capillaries were tortuous (p < 0.00001 compared to healthy controls). In 41.6 % the number of capillaries was markedly reduced (<7 capillaries/mm). The mean number of capillaries was 8.4 +/- 2.6/mm in HeFH and 12.2 +/- 1.4/mm in healthy controls (p < 0.00001). In 100 % of the sample size capillary blood flow was slowed down (p < 0.00001). In 50 % of the sample size a blood "sludge" phenomenon was seen (p < 0.00001). No gender differences were detected. Sludge phenomenon was seen only in those with LDL-C over 99th centile (p < 0.00001). Conclusion: NCF allows the identification of an early peripheral microvascular dysfunction in HeFH children which is similar to that already seen in atherosclerotic disease. Prompt identification of these capillary abnormalities may be crucial in implementing early prevention measures.
引用
收藏
页数:5
相关论文
共 43 条
  • [31] Systematic Review and Metaanalysis of Statins for Heterozygous Familial Hypercholesterolemia in Children: Evaluation of Cholesterol Changes and Side Effects
    Clodagh S. O’Gorman
    Mary F. Higgins
    Michael B. O’Neill
    Pediatric Cardiology, 2009, 30 : 482 - 489
  • [32] Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance
    Yanagi, K
    Yamashita, S
    Kihara, S
    Nakamura, T
    Nozaki, S
    Nagai, Y
    Funahashi, T
    KamedaTakemura, K
    Ueyama, Y
    Jiao, S
    Kubo, M
    Tokunaga, K
    Matsuzawa, Y
    ATHEROSCLEROSIS, 1997, 132 (01) : 43 - 51
  • [33] Heterozygous familial hypercholesterolemia in children: Low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations
    Torres, AL
    Moorjani, S
    Vohl, MC
    Gagne, C
    Lamarche, B
    Brun, LD
    Lupien, PJ
    Despres, JP
    ATHEROSCLEROSIS, 1996, 126 (01) : 163 - 171
  • [34] Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
    Casula, Manuela
    Gazzotti, Marta
    Capra, Maria Elena
    Olmastroni, Elena
    Galimberti, Federica
    Catapano, Alberico L.
    Pederiva, Cristina
    ATHEROSCLEROSIS, 2023, 385
  • [35] Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi, Zanfina
    Norman, Richard
    Pang, Jing
    Liew, Danny
    Zoungas, Sophia
    Sijbrands, Eric
    Ference, Brian A.
    Wiegman, Albert
    Watts, Gerald F.
    ATHEROSCLEROSIS, 2020, 304 : 1 - 8
  • [36] The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
    Gazzotti, Marta
    Casula, Manuela
    Bertolini, Stefano
    Capra, Maria Elena
    Olmastroni, Elena
    Catapano, Alberico Luigi
    Pederiva, Cristina
    FRONTIERS IN GENETICS, 2022, 13
  • [37] Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: Effect of pravastatin
    Ryu, Sung Kee
    Hutten, Barbara A.
    Vissers, Maud N.
    Wiegman, Albert
    Kastelein, John J. P.
    Tsimikas, Sotirios
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (01) : 50 - 56
  • [38] Early Discovery of Children With Lysosomal Acid Lipase Deficiency With the Universal Familial Hypercholesterolemia Screening Program
    Sustar, Ursa
    Groselj, Urh
    Podkrajsek, Katarina Trebusak
    Mlinaric, Matej
    Kovac, Jernej
    Thaler, Martin
    Torkar, Ana Drole
    Skarlovnik, Ajda
    Battelino, Tadej
    Hovnik, Tinka
    FRONTIERS IN GENETICS, 2022, 13
  • [39] Flow cytometric assessment of LDL receptor activity peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia
    Raungaard, B
    Heath, F
    Brorholt-Petersen, JU
    Jensen, HK
    Faergeman, O
    CYTOMETRY, 1999, 36 (01): : 52 - 59
  • [40] Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study
    Sanin, Veronika
    Schmieder, Raphael
    Ates, Sara
    Schlieben, Lea Dewi
    Wiehler, Jens
    Sun, Ruoyu
    Decker, Manuela
    Sander, Michaela
    Holdenrieder, Stefan
    Kohlmayer, Florian
    Friedmann, Anna
    Mall, Volker
    Feiler, Therese
    Dressler, Arne
    Strom, Tim M.
    Prokisch, Holger
    Meitinger, Thomas
    von Scheidt, Moritz
    Koenig, Wolfgang
    Leipold, Georg
    Schunkert, Heribert
    MEDIZINISCHE GENETIK, 2022, 34 (01) : 41 - 51